Skip to Main Content

Exclusive

Latest

Exclusive Rachel Cohrs Zhang

STAT Plus: PhRMA dues fell almost $100 million as major drugmakers exited

Exclusive Tara Bannow

STAT Plus: New York health insurer, executive agree to up to $100 million settlement over Medicare fraud tied to improper diagnoses

Politics Rachel Cohrs Zhang

STAT Plus: Congress strikes deal to rein in PBMs after years of debate

Exclusive Rachel Cohrs Zhang and John Wilkerson

STAT Plus: The pharma industry isn’t lobbying against RFK Jr.’s nomination for a top health role

Exclusive Lev Facher

Rhode Island set to open first supervised consumption site for illicit drugs outside NYC

Exclusive Allison DeAngelis

STAT Plus: Atlas Venture completes ‘disciplined’ $450 million fundraise

Exclusive Rachel Cohrs Zhang

STAT Plus: Talks over big end-of-year health package heat up in Congress

Exclusive Allison DeAngelis

STAT Plus: Recursion, the AI drug development company, cuts more jobs after finalizing Exscientia merger

All Coverage

Exclusive Katie Palmer

STAT Plus: Children’s Hospital Los Angeles tests generative AI to translate discharge notes into Spanish

Exclusive Sarah Owermohle

STAT Plus: Ted Kennedy Jr. expresses concern about Trump’s ‘flagrant disregard’ for public health

advertisement

Exclusive Bob Herman

STAT Plus: Warren wants close FTC scrutiny of drug distributors buying cancer medical groups

Exclusive Lizzy Lawrence

STAT Plus: Michelle Tarver to lead FDA medical device center

Exclusive Katie Palmer

STAT Plus: Senators demand answers on telehealth platforms from Pfizer and Eli Lilly

Exclusive Jonathan Wosen

STAT Plus: Amid a rough biotech job market, fewer biomedical Ph.D. grads head for industry, data show

Exclusive Allison DeAngelis

STAT Plus: Biotech veteran John Maraganore raises $135 million for his ‘next-generation RNAi’ startup

Exclusive Megan Molteni

STAT Plus: A pariah in science, the ‘CRISPR babies’ researcher gains support from a U.S. cryptocurrency entrepreneur

Exclusive Matthew Herper

STAT Plus: Janet Woodcock, former FDA official, joins board of patient group focused on ‘rediscovering’ old drugs

Exclusive Lev Facher

To aid addiction treatment, lawmakers tell DEA to back off buprenorphine enforcement

Exclusive Lev Facher

STAT Plus: Key lawmakers pressure Biden to preserve telehealth prescribing of effective addiction treatment

Exclusive Allison DeAngelis

STAT Plus: DCVC Bio founders look for more quick returns, less overhyped AI, with new $400 million fund

Exclusive Bob Herman, J. Emory Parker, Lizzy Lawrence, Tara Bannow, and Mohana Ravindranath

STAT Plus: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion

Politics John Wilkerson and Rachel Cohrs Zhang

STAT Plus: Hassan indicates she’s open to tweaks on site-neutral payment reforms

Exclusive John Wilkerson and Rachel Cohrs Zhang

STAT Plus: Generic drug lobby taps former BIO exec as new CEO

Exclusive Jonathan Wosen

STAT Plus: The little-known Chinese biotech whose cancer drug beat Keytruda has global ambitions

Exclusive Lev Facher and Mario Aguilar

STAT Plus: Lawmakers push to let telehealth providers keep prescribing stimulants and addiction treatment

Exclusive Rachel Cohrs Zhang

STAT Plus: A mysterious anti ‘Big Pharma’ bus is barnstorming swing states

Exclusive Bob Herman

STAT Plus: Amazon cuts ties with fertility benefits company Progyny

Exclusive Lizzy Lawrence

STAT Plus: FDA’s new head of device safety held senior role at company troubled by safety warnings

Exclusive John Wilkerson

STAT Plus: Cassidy seeks to exempt small biotechs from Medicare drug price negotiation